Current Report Filing (8-k)
24 June 2017 - 6:36AM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of
the Securities Exchange Act of 1934
Date
of Report (Date of Earliest Event Reported):
June 20, 2017
Ekso Bionics Holdings, Inc.
(Exact
Name of Registrant as specified in its charter)
Nevada
|
001-37854
|
99-0367049
|
(State or Other Jurisdiction of
Incorporation)
|
(Commission File Number)
|
(IRS Employer
Identification No.)
|
1414 Harbour Way South, Suite 1201
Richmond, California 94804
(Address of principal executive offices,
including zip code)
(510) 984-1761
(Registrant’s telephone number, including
area code)
Not Applicable
(Registrant’s name or former address,
if change since last report)
Check the appropriate box below
if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following
provisions (
see
General Instruction A.2. below):
|
☐
|
Written communications pursuant to Rule 425 under the
Securities Act (17 CFR 230.425)
|
|
☐
|
Soliciting material pursuant to Rule 14a-12 under the
Exchange Act (17 CFR 240.14a-12)
|
|
☐
|
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange
Act (17 CFR 240.14d-2(b))
|
|
☐
|
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange
Act (17 CFR 240.13e-4(c))
|
Indicate by check mark whether the registrant is
an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of
the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging
growth company
☒
If an emerging growth company, indicate by check mark if the
registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards
provided pursuant to Section 13(a) of the Exchange Act. ☒
|
Item 5.07
|
Submission of Matter to a Vote of Security Holders
|
The following provides a summary of votes
cast for the proposals on which the stockholders of Ekso Bionics Holdings, Inc. (the “Company”) voted at the annual
meeting of stockholders held on June 20, 2017 (the “Annual Meeting”):
Proposal 1
. The election of eight
directors to serve until the next annual meeting of stockholders and the election of their successors.
Director Nominee
|
|
For
|
|
Withheld
|
|
Broker Non-Votes
|
Steven Sherman
|
|
5,648,818
|
|
1,032,759
|
|
10,376,874
|
Thomas Looby
|
|
6,347,375
|
|
334,202
|
|
10,376,874
|
Daniel Boren
|
|
6,361,036
|
|
320,541
|
|
10,376,874
|
Marilyn Hamilton
|
|
5,858,101
|
|
823,476
|
|
10,376,874
|
Howard Palefsky
|
|
6,355,865
|
|
325,712
|
|
10,376,874
|
Jack Peurach
|
|
6,153,656
|
|
527,921
|
|
10,376,874
|
Stanley Stern
|
|
5,841,139
|
|
840,438
|
|
10,376,874
|
Amy Wendell
|
|
6,176,786
|
|
504,791
|
|
10,376,874
|
Proposal 2.
Approval of the Ekso
Bionics Holdings, Inc. 2017 Employee Stock Purchase Plan.
For
|
|
Against
|
|
Abstain
|
|
Broker Non-Votes
|
6,104,867
|
|
419,302
|
|
157,408
|
|
10,376,874
|
Proposal 3.
Approval of an amendment
to the Amended and Restated 2014 Equity Incentive Plan to increase the maximum number of shares available for grant from 3,714,285
shares to 4,714,285 shares.
For
|
|
Against
|
|
Abstain
|
|
Broker Non-Votes
|
5,015,192
|
|
1,593,942
|
|
72,443
|
|
10,376,874
|
Proposal 4.
The ratification of
the appointment of OUM & Co., LLP as the Company’s independent registered public accounting firm for the fiscal year
ending December 31, 2017.
For
|
|
Against
|
|
Abstain
|
|
Broker Non-Votes
|
16,419,641
|
|
389,483
|
|
249,327
|
|
0
|
SIGNATURE
Pursuant to the requirements
of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the
undersigned thereunto duly authorized.
|
EKSO BIONICS HOLDINGS, INC.
|
|
|
|
|
|
|
|
|
By:
|
/s/
Maximilian Scheder-Bieschin
|
|
|
Name:
|
Maximilian Scheder-Bieschin
|
|
|
Title:
|
Chief Financial Officer
|
|
Dated: June 23, 2017
|
|
|
|
|
|
|
|
Ekso Bionics (NASDAQ:EKSO)
Historical Stock Chart
From Apr 2024 to May 2024
Ekso Bionics (NASDAQ:EKSO)
Historical Stock Chart
From May 2023 to May 2024